Abiopharma

News list

Singhal Priya 🟡 adjusted position in 1.3K shares (1 derivative) of BIOGEN INC. (BIIB) at $133.55 Transaction Date: Aug 29, 2025 | Filing ID: 021083

Full text

News bot Sept. 2, 2025, 9:57 p.m.
🔍 Singhal Priya (Executive)

Company: BIOGEN INC. (BIIB)

Report Date: 2025-08-29
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,669
- Total shares sold: 2,993
Detailed Transactions and Holdings:
- Acquired 1,669 shares of Common Stock (Direct)
  Date: 2025-08-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,096.14 | transaction_form_type: 4
- Sold 807 shares of Common Stock at $132.22 per share (Direct)
  Date: 2025-08-29 | Code: F | equity_swap_involved: 0 | shares_owned_after: 6,289.14 | transaction_form_type: 4
- Sold 517 shares of Common Stock at $133.55 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,772.14 | transaction_form_type: 4
- Sold 1,669 shares of Restricted Stock Unit (Derivative)
  Date: 2025-08-29 | Code: M | Expires: 2025-09-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This award was granted to the reporting person on September 1, 2022 and will vest in three equal installments on each anniversary of the grant date.